ProCE Banner Activity

Foco da pesquisa: alcançar equilíbrio hemostático na hemofilia com terapias emergentes

PDF

Read this text module in Brazilian Portuguese to learn from global experts as they provide an overview of the evolving treatment landscape of hemophilia, including novel agents for rebalancing homeostasis, best practices for integrating these agents into clinical practice, and how to address common barriers to care and patient adherence.

Released: April 05, 2024

Expiration: April 04, 2025

Share

Faculty

Miguel A. Escobar

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Division of Hematology
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

Margareth C. Ozelo

Margareth C. Ozelo, MD, PhD

Professor of Hematology and Transfusion Medicine
Department of Internal Medicine - School of Medical Sciences UNICAMP
Director of Hematology Division, Hemocentro UNICAMP, University of Campinas
University of Campinas
Campinas, Sao Paulo, Brazil

Runhui Wu

Runhui Wu, MD, PhD

Hemophilia Comprehensive Care Center
Hematology Center
National Center for Children’s Health, China
Beijing Children’s Hospital, Capital Medical University
Beijing, China

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Sanofi.

Sanofi

Disclosure

Primary Author

Miguel A. Escobar, MD

Professor of Medicine and Pediatrics
Division of Hematology
McGovern Medical School
Director
Gulf States Hemophilia and Thrombophilia Center
Houston, Texas

Miguel A. Escobar, MD: consultant/advisor/speaker: Bayer, BioMarin, CSL Behring, HEMA Biologics, LFB, Magellan, Novo Nordisk, Pfizer, Regeneron, Roche/Genentech, Sanofi, Takeda.

Margareth C. Ozelo, MD, PhD

Professor of Hematology and Transfusion Medicine
Department of Internal Medicine - School of Medical Sciences UNICAMP
Director of Hematology Division, Hemocentro UNICAMP, University of Campinas
University of Campinas
Campinas, Sao Paulo, Brazil

Margareth C. Ozelo, MD, PhD: researcher: Bayer, BioMarin, Pfizer, Roche, Sanofi, Takeda; consultant/advisor/speaker: BioMarin, Novo Nordisk, Pfizer, Roche, Sanofi, Takeda.

Runhui Wu, MD, PhD

Hemophilia Comprehensive Care Center
Hematology Center
National Center for Children’s Health, China
Beijing Children’s Hospital, Capital Medical University
Beijing, China

Runhui Wu, MD, PhD: researcher: Bayer-China, Sinocelltech Group Limited; consultant/speaker: Bayer, Novo Nordisk, Pfizer, Roche, Sanofi, Sinocelltech Group Limited, Takeda.